The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
Abstract
Despite significant advances in pharmacologic therapy of depression over the past two decades, a substantial proportion of patients fail to respond or experience only partial response to serotonin re-uptake inhibitor antidepressants, resulting in chronic functional impairment. There appears to be a pattern of symptoms that are inadequately addressed by serotonergic antidepressants — loss of pleasure, loss of interest, fatigue and loss of energy. These symptoms are key to the maintenance of drive and motivation. Although these symptoms are variously defined, they are consistent with the concept of `decreased positive affect'. Positive affect subsumes a broad range of positive mood states, including feelings of happiness (joy), interest, energy, enthusiasm, alertness and selfconfidence. Although preliminary, there is evidence to suggest that antidepressants that enhance noradrenergic and dopaminergic activity may afford a therapeutic advantage over serotonergic antidepressants in the treatment of symptoms associated with a reduction in positive affect. Dopaminergic and noradrenergic agents, including the dual acting norepinephrine and dopamine re-uptake inhibitors, have demonstrated antidepressant activity in the absence of serotonergic function, showing similar efficacy to both tricyclic and serotonin re-uptake inhibitor antidepressants. Moreover, the norepinephrine and dopamine re-uptake inhibitor bupropion has been shown to significantly improve symptoms of energy, pleasure and interest in patients with depression with predominant baseline symptoms of decreased pleasure, interest and energy. Focusing treatment on the predominant or driving symptomatology for an individual patient with major depression could potentially improve rates of response and remission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, many antidepressants are able to ameliorate the inability to experience pleasure and to reduce the intensity of negative emotions (Nutt et al., 2007).”
From Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment (2021) · cites this paper as Nutt et al., 2007
In the citing paper
“Anhedonia is often conceptualized as the behavioral manifestation of altered reward processing in depressed patients (Beck, 2004; Nutt et al., 2007; Webb et al., 2016; Winer and Salem, 2015), and may underlie many of the profound social impairments that are central to depression (Kupferberg et al., 2016).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Nutt et al., 2007
Citations
Cites
(2005) · Choice Reviews Online · doi:10.5860/choice.43-0626 · Cited by 4,674
Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications
Clark, L. A., & Watson, D. (1991) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.100.3.316 · Cited by 4,601
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Depue, R. A., & Collins, P. F. (1999) · Behavioral and Brain Sciences · doi:10.1017/s0140525x99002046 · Cited by 2,046
The ESEMeD/MHEDEA 2000 Investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00327.x · Cited by 1,819
Self-citationPositive and negative affectivity and their relation to anxiety and depressive disorders.
Watson, D., Clark, L. A., & Carey, G. (1988) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.97.3.346 · Cited by 1,795
Research works printed but not linked: 32
- Alonso J., 2000, Acta Psychiatr Scand, 109, 21
- Alonso J., 2000, Acta Psychiatr Scand, 109, 38
- Baldwin D.S., J Clin Psychiatry
- Bourin M., 1999, Encephale, 25, 21
- Bremner J.D., 1984, J Clin Psychiatry, 45, 56
- Brothers L., 1995, Neurophysiology of the perception of intentions by primates
- Clerc, G.E., 1994, Psychopharmacol, 9, 139
- Delgado P.L., 2000, J Clin Psychiatry, 61, 7
- Delgado P.L., 2004, J Clin Psychiatry, 65, 25
- Demyttenaere K., 2004, Int J Neuropharmacol, 8, 93
- Fava M., 2005, J Clin Psychiatry, 7, 106
- Feighner J.P., 1991, J Clin Psychiatry, 52, 329
- 10.1002/(sici)1098-2396(20000601)36:3<205::aid-syn5>3.0.co;2-d · DOI · Paper page
- Hoehn-Saric R., 1991, J Clin Psychiatry, 52, 131
- Jamerson B., 2003, Psychopharmacol Bull, 37, 67
- Jefferson J.W., J Clin Psychiatry
- Maurice-Tison S., 1998, Br J Gen Pract, 48, 1245
- Montgomery S.A., 1997, J. Psychopharmacol, 11, S9
- Nelson J.C., 2005, Psychiatry, 13, 520
- Nemeroff C.B., 2002, Psychopharmacol Bull, 36, 106
- Nierenberg A.A., 2001, J Clin Psychiatry, 62, 5
- 10.1002/(sici)1520-6394(1996)4:6<312::aid-da7>3.0.co;2-d · DOI
- Sitland-Marken P.A., 1990, J Clin Psychiatry, 51, 68
- Stahl S.M., 2003, J Clin Psychiatry, 64, 6
- Stahl S.M., 2004, J Clin Psychiatry, 6, 159
- Thase M.E., 2003, J Clin Psychiatry, 64, 3
- Tylee A.T., 1993, Br J Gen Pract, 43, 327
- Tylee A., 1999, Int Clin Psychopharmacol, 14, 139
- 10.1037/0022-3514.47.1.127 · doi:10.1037/0022-3514.47.1.127 · Paper page
- 10.1037/0021-843x.104.1.15 · DOI · Paper page
- Willner P., 1995, Adv Biochem Psychopharmacol, 49, 19
- Willner P., 2000, Dopaminergic mechanisms in depression and mania
Cited by
Neural mechanisms of the cognitive model of depression.
Disner, S. G., Beevers, C. G., Haigh, E. A. P., & Beck, A. T. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3027 · Cited by 1,718
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
A common neurobiology for pain and pleasure
Leknes, S., & Tracey, I. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2333 · Cited by 784
Dopamine system dysregulation in major depressive disorders
Belujon, P., & Grace, A. A. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx056 · Cited by 754
Treadway, M. T., Bossaller, N. A., Shelton, R. C., & Zald, D. H. (2012) · Journal of Abnormal Psychology · doi:10.1037/a0028813 · Cited by 733
“Moreover, our results are consistent with significant prior evidence that SSRI treatments fail to address symptoms related to motivation and anhedonia in MDD (Nutt et al., 2007; Shelton & Tomarken, 2001).”
Metadata
- Authors
- Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S.
- Affiliations
- University of Bristol (GB)
- UZ Gasthuisberg, Adult and Geriatric Psychiatry, Belgium
- Department of Psychiatry, University of Szeged, Hungary
- Nordfjord Psychiatric Centre, Sjukehusvegen
- Faculté de Médecine Pharmacologie Clinique, France
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Carrasco Department of Clinical Psychiatry, U. Complutense de Madrid, Hospital Universitario Clinico San Carlos de Madrid, Spain
- Neuroscience Education Institute (US)
- Corresponding author
- Nutt, David
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2007-07
- Volume
- 21
- Issue
- 5
- Pages
- 461-471
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2115714588
- Cited by
- 366
- References
- 150
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 15 · 2022: 22 · 2021: 27 · 2020: 15 · 2019: 22 · 2018: 24 · 2017: 16 · 2016: 30 · 2015: 27 · 2014: 30 · 2013: 19 · 2012: 22
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- depression, catecholamines, noradrenergic antidepressants, bupropion, serotonin reuptake inhibitors, treatment-resistant depression, anergia, fatigue, motivation, antidepressant response
- MeSH terms
- Affect, Antidepressive Agents, Catecholamines, Depressive Disorder, Major, Major Depressive Disorder, Dopamine, Humans, Norepinephrine, Remission Induction, Serotonin, Neurotransmitter Uptake Inhibitors, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Patient Selection, Adrenergic Uptake Inhibitors, Dopamine Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. https://app.cochat.ai/papers/10.1177/0269881106069938
- The paper
- Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007). The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. Journal of Psychopharmacology. https://doi.org/10.1177/0269881106069938
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.